Feb 29 |
DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates
|
Feb 29 |
DermTech GAAP EPS of -$0.56 in-line, revenue of $3.92M misses by $0.11M
|
Feb 29 |
DermTech Reports Fourth-Quarter 2023 Financial Results
|
Feb 29 |
Earnings Scheduled For February 29, 2024
|
Feb 28 |
DermTech Q4 2023 Earnings Preview
|
Feb 13 |
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results
|
Jan 31 |
DermTech to lay off 30 more workers as it focuses on melanoma test
|
Jan 31 |
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
|
Jan 18 |
DermTech study finds melanoma test effective for all skin types
|
Jan 18 |
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
|